Article Details

Merck, Eisai drug combo nabs FDA nod as first-line kidney cancer therapy

Retrieved on: 2021-08-12 22:29:36

Tags for this article:

Click the tags to see associated articles and topics

Merck, Eisai drug combo nabs FDA nod as first-line kidney cancer therapy. View article details on hiswai:

Excerpt

The safety information on Keytruda's label warns of the risk of immune system-related reactions, potentially severe or fatal, that may develop in any ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up